PODOCYTURIA IN FABRY DISEASE IS ELEVATED IN UNTREATED VS TREATED ADULT PATIENTS AND DOES NOT CORRELATE WITH PROTEINURIA OR RENAL FUNCTION

被引：0
|
作者：
Trimarchi, Hernan [1 ]
Canzonieri, Romina [2 ]
Schiel, Amalia [2 ]
Politei, Juan [3 ]
Andrews, Jose [1 ]
Forrester, Mariano [1 ]
Alonso, Mirta [2 ]
Lombi, Fernando [1 ]
Pomeranz, Vanesa [1 ]
Karl, Alejandra [1 ]
Rengel, Tatiana [1 ]
Muryan, Alexis [2 ]
Zotta, Elsa [4 ]
机构：
[1] Hosp Britan Buenos Aires, Nephrol, Buenos Aires, DF, Argentina
[2] Hosp Britan Buenos Aires, Biochem, Buenos Aires, DF, Argentina
[3] Fdn Estudio Enfermedades Neurometab, Lab Neuroquim Dr NA Chamoles, Buenos Aires, DF, Argentina
[4] Univ Buenos Aires, Fac Med, Buenos Aires, DF, Argentina
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2015年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP178
引用
收藏
页数：1
相关论文
共 50 条
  • [31] RENAL SURVIVAL AND COMPLETE REMISSION IN STEROID-TREATED VS UNTREATED ADULT FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
    DILLON, JJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 417 - 417
  • [32] Different monitoring patterns in treated and untreated patients with Fabry disease: Analysis of a United States claims database
    Maksimova, Irina
    Dumitriu, Alexandra
    Crespo, Ana
    Miles, Gandarvaka
    Ocampo, Andrea
    Ip, Queeny
    Jordan, Michael
    Petruski-Ivleva, Natalia
    Araujo, Roberto
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [33] Low alpha-galactosidase A activity among haemodyalisis patients: Does it correlate with Fabry disease mutations?
    Pereira, Vanessa G.
    Braga, Marion C.
    Yamamoto, Joyce U. S.
    Martins, Ana M.
    Pesquero, Joao B.
    D'Almeida, Vania
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (02) : S93 - S94
  • [34] Effect of angiotensin-converting enzyme inhibitors on proteinuria in patients with Fabry disease treated with enzyme replacement therapy
    Vujkovac, B
    Cokan, A
    Verovnik, F
    Benko, D
    Sabovic, M
    ACTA PAEDIATRICA, 2006, 95 : 137 - 137
  • [35] EFFECT OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS ON PROTEINURIA IN PATIENTS WITH FABRY DISEASE TREATED WITH ENZYME REPLACEMENT THERAPY
    Vujkovac, Bojan
    Cokan, Andreja
    Verovnik, Franc
    Sabovic, Miso
    Benko, Davorin
    NEPHROLOGY, 2005, 10 : A227 - A227
  • [36] A COST ANALYSIS ON RENAL DISEASE PROGRESSION OF FABRY DISEASE PATIENTS TREATED WITH AGALSIDASE BETA BASED ON RENAL DISEASE STAGE IN COLOMBIA
    Londono, S.
    Ossa, M. E.
    Solano, D. A.
    VALUE IN HEALTH, 2023, 26 (06) : S112 - S112
  • [37] Design of a prospective, multicenter, multinational, observational safety and outcomes registry in Fabry disease patients treated with migalastat and untreated patients
    Sunder-Plassmann, Gere
    Bichet, Daniel G.
    Davidonis, Martynas
    Germain, Dominique P.
    Giugliani, Roberto
    Hopkin, Robert
    Jovanovic, Ana
    Linhart, Ales
    Nicholls, Kathleen
    Nordbeck, Peter
    Feldt-Rasmussen, Ulla
    Rutecki, Jasmine
    Giuliano, Joe
    Skuban, Nina
    Politei, Juan
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S140 - S141
  • [38] Impact of proteinuria on long-term renal function in patients with gastrointestinal cancer treated with ramucirumab
    Hirata, T.
    Okada, Y.
    Nozaki, M.
    Tashiro, H.
    Nakano, K.
    ANNALS OF ONCOLOGY, 2019, 30 : 47 - 47
  • [39] Non-significant impact of proteinuria on renal function in Japanese patients with metastatic renal cell carcinoma treated with axitinib
    Hideaki Miyake
    Ken-ichi Harada
    Satoshi Imai
    Akira Miyazaki
    Masato Fujisawa
    International Journal of Clinical Oncology, 2015, 20 : 796 - 801
  • [40] Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension
    Voyaki, SM
    Staessen, JA
    Thijs, L
    Wang, JG
    Efstratopoulos, AD
    Birkenhäger, WH
    de Leeuw, PW
    Leonetti, G
    Nachev, C
    Rodicio, JL
    Tuomilehto, J
    Fagard, R
    JOURNAL OF HYPERTENSION, 2001, 19 (03) : 511 - 519
12345